Table 6.

Pathological results

	Neoadjuvant ( n  = 80)	Adjuvant ( n  = 90)	P
Clinical/pathological tumor stage			0.323/<0.001
T0	0 (0%)/12 (15.0%)	0 (0%)/0 (0%)
T1	4 (5.0%)/9 (11.2%)	1 (1.1%)/1 (1.1%)
T2	7 (8.8%)/24 (30.0%)	10 (11.1%)/8 (8.9%)
T3	16 (20.0%)/15 (18.8%)	13 (14.4%)/16 (17.8%)
T4	53 (66.3%)/20 (25.0%)	66 (73.4%)/65 (72.2%)
Nodal status			<0.001
N0	47 (58.8%)	13 (14.4%)
N1 (one to two nodes involved)	13 (16.3%)	20 (22.2%)
N2 (three to six nodes involved)	11 (13.8%)	25 (27.8%)
N3 (more than seven nodes involved)	9 (11.3%)	32 (35.6%)